We are live on ! Find out more
INAB icon

IN8bio
INAB

17 hedge funds and large institutions have $2.42M invested in IN8bio in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

13% more funds holding

Funds holding: 15 → 17 (+2)

0.25% less ownership

Funds ownership: 0.42% → 0.16% (-0.25%)

56% less capital invested

Capital invested by funds: $5.5M → $2.42M (-$3.08M)

Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$132K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$117K
3
PM
Precept Management
Texas
+$112K
4
WAM
Warberg Asset Management
Illinois
+$33.6K
5
HighTower Advisors
HighTower Advisors
Illinois
+$31.7K

Top Sellers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
-$1.88M
2
BRF
B. Riley Financial
California
-$582K
3
NCM
Nantahala Capital Management
Connecticut
-$359K
4
VC
Voss Capital
Texas
-$291K
5
SIG
Stonegate Investment Group
Alabama
-$76.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
VC
1
Voss Capital
Texas
$759K -$291K -4,336 -26%
SIG
2
Stonegate Investment Group
Alabama
$469K -$76.5K -1,139 -13%
Vanguard Group
3
Vanguard Group
Pennsylvania
$342K +$132K +1,961 +53%
SPC
4
Sigma Planning Corp
Michigan
$199K +$2.28K +34 +1%
BCM
5
Bridgeway Capital Management
Texas
$149K +$31.4K +467 +23%
Ensign Peak Advisors
6
Ensign Peak Advisors
Utah
$141K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$105K +$117K +1,745 New
PM
8
Precept Management
Texas
$101K +$112K +1,667 New
BlackRock
9
BlackRock
New York
$47K -$11.4K -170 -18%
WAM
10
Warberg Asset Management
Illinois
$30K +$33.6K +500 New
UAS
11
United Asset Strategies
New York
$28K +$31.4K +467 New
HighTower Advisors
12
HighTower Advisors
Illinois
$28K +$31.7K +472 New
UBS Group
13
UBS Group
Switzerland
$18K +$10.5K +157 +117%
TRCT
14
Tower Research Capital (TRC)
New York
$4K -$806 -12 -16%
Morgan Stanley
15
Morgan Stanley
New York
$3K +$1.14K +17 +52%
Capital World Investors
16
Capital World Investors
California
– -$1.88M -25,825 Closed
BRF
17
B. Riley Financial
California
– -$582K -8,584 Closed
NCM
18
Nantahala Capital Management
Connecticut
– -$359K -4,960 Closed
TSS
19
Two Sigma Securities
New York
– -$67K -995 Closed
Wells Fargo
20
Wells Fargo
California
– +$67 +1 +100%
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
– +$336 +5 New

INAB Hedge Fund Activity: Q3 2022 in Review

17 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in IN8bio (INAB) for Q3 2022, worth a combined $2.42M — down 56% from $5.5M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new INAB positions and 4 closed out — a net gain of 2 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $132K. The largest seller was Capital World Investors, exiting entirely with an estimated $1.88M sold.

  • 17 institutional investors held IN8bio (INAB) as of Q3 2022, up from 15 in Q2 2022.
  • Funds reported $2.42M of IN8bio stock for Q3 2022, down 56% quarter-over-quarter.
  • 6 funds opened new IN8bio positions in Q3 2022 and 4 closed out, a net change of +2 holders.
  • The largest IN8bio buyer in Q3 2022 was Vanguard Group, an estimated $132K added.
  • The largest IN8bio seller in Q3 2022 was Capital World Investors, an estimated $1.88M sold.

Based on aggregated 13F filings for Q3 2022.